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White to beige conversion in 
PDE3B KO adipose tissue through 
activation of AMPK signaling and 
mitochondrial function
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Karin Berger4, Emilia Guirguis1, Young Hun Choi1, Dan M. Schimel5, Angel M. Aponte6, 
Sunhee Park1, Eva Degerman4 & Vincent C. Manganiello1
Understanding mechanisms by which a population of beige adipocytes is increased in white adipose 
tissue (WAT) reflects a potential strategy in the fight against obesity and diabetes. Cyclic adenosine 
monophosphate (cAMP) is very important in the development of the beige phenotype and activation 
of its thermogenic program. To study effects of cyclic nucleotides on energy homeostatic mechanisms, 
mice were generated by targeted inactivation of cyclic nucleotide phosphodiesterase 3b (Pde3b) gene, 
which encodes PDE3B, an enzyme that catalyzes hydrolysis of cAMP and cGMP and is highly expressed 
in tissues that regulate energy homeostasis, including adipose tissue, liver, and pancreas. In epididymal 
white adipose tissue (eWAT) of PDE3B KO mice on a SvJ129 background, cAMP/protein kinase A (PKA) 
and AMP-activated protein kinase (AMPK) signaling pathways are activated, resulting in “browning” 
phenotype, with a smaller increases in body weight under high-fat diet, smaller fat deposits, increased 
β-oxidation of fatty acids (FAO) and oxygen consumption. Results reported here suggest that PDE3B 
and/or its downstream signaling partners might be important regulators of energy metabolism in 
adipose tissue, and potential therapeutic targets for treating obesity, diabetes and their associated 
metabolic disorders.
Obesity is a major risk factor for type 2 diabetes and cardiovascular disease. White adipose tissue (WAT), a highly 
regulated and dynamic secretory organ, affects body fat and energy utilization through storage and turnover/
hydrolysis of triglycerides. In addition, via production of endocrine factors, adipocytokines, and lipids, WAT reg-
ulates and integrates important physiological pathways, including satiety, energy utilization, glucose sensitivity, 
insulin sensitivity, and inflammation1. WAT, however, also contributes to metabolic dysregulation that character-
izes insulin resistance and obesity-related metabolic and cardiovascular complications2,3.
Brown adipose tissue (BAT), enriched in mitochondria, regulates adaptive thermogenesis in small rodents 
and mammalian newborns. Brown adipocytes express mitochondria uncoupling protein 1 (UCP1), which shunts 
energy derived during mitochondrial β -oxidation of fatty acids (FAO) from ATP formation to thermogenesis4,5. 
In general, induction/activation of BAT in rodents is associated with decreased adiposity, improved responsive-
ness to insulin, and reduced serum free fatty acids (FFA), i.e., a “lean” phenotype which may confer protection 
against diabetes, obesity, and their metabolic sequelae6–9. Although it is not essential for BAT differentiation, 
PPARγ co-activator 1 alpha (PGC-1α ) is a critical transcriptional activator of cAMP-mediated mitochondrial 
biogenesis and induction of the thermogenic program10. Transfection of cultured human white adipocytes 
with PGC-1α induced expression of UCP1 and mitochondrial proteins, and increased FAO11. Furthermore, 
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PGC-1α -responsive genes involved in FAO and oxidative phosphorylation are upregulated by thiazolidinediones 
(TZDs)12,13, and are downregulated in skeletal muscle and adipose tissue in insulin-resistant states14–16. Recent 
studies have demonstrated the presence of substantial amounts of active BAT in adult human WAT depots, and 
the amount of BAT inversely correlated with BMI (body-mass index), suggesting that human BAT may play a role 
in regulation of human obesity and energy homeostasis17–19. Since white adipocytes and “constitutive” brown adi-
pocytes (e.g., in interscapular brown-fat depots) develop from different precursors and genetic lineages, and since 
constitutive brown adipocytes and ectopic brown adipocytes (e.g., arising in WAT depots) exhibit distinct but 
overlapping patterns of gene expression20,21, the inducible, ectopic “brown-like” cells are referred to as “beige or 
brite” adipocytes22,23. Thus, understanding mechanisms (and, thereby, identifying possible drug targets) whereby 
beige adipocytes arise in WAT reflects a potential strategy in the fight against obesity and diabetes8,9,24,25.
cAMP/PKA signaling pathways play critical roles in differentiation of WAT and BAT, and regulation of energy 
homeostasis25. More recently, cardiac natriuretic peptides were also found to induce “browning”, mediated by 
activation of guanylyl cyclase and cGMP-signaling and activation of PKG and p38 MAPK26. Via upregulation of 
expression of PGC-1α and other genes, cAMP/PKA-signaling increases mitochondrial biogenesis and modulates 
differentiation of BAT and induction of its thermogenic program27. Inhibition of PDE3B by endogenous cGMP 
might be involved in the reported stimulatory effects of NO and cGMP on BAT differentiation28,29. In adipocytes, 
insulin-induced activation of PDE3B is involved in the inhibition of cAMP-stimulated lipolysis by insulin. PDE3B 
also seems to be important in effects of insulin on glucose uptake and lipogenesis in adipocytes, and in regulation 
of AMPK activity30–32.
Current data suggest that in WAT, PR domain containing 16 (PRDM16) protein is a critical determinant of 
ectopic “browning”, via its simultaneous induction of beige and suppression of WAT genes33–35. PRDM16 inter-
acts with, and strongly coactivates transcription factors, including PGC-1α and PPARα , to induce browning in 
WAT depots20,21,35,36. Via interaction with repressors c-terminal binding protein-1 (CtBP-1) and CtBP-2, PRDM16 
inhibits expression of WAT genes37. In response to cAMP, PGC-1α is the dominant regulator of mitochondrial 
biogenesis and thermogenic and oxidative metabolic pathways38,39. The coactivator function of PGC-1α in mod-
ulating gene expression seems to be regulated, in a feedback fashion, by leucine-rich protein 130 (LRP130), a 
PGC-1α -inducible factor40.
AMP-activated protein kinase (AMPK), a sensor or gauge of cellular energy, also plays a critical role in modu-
lating energy homeostasis by regulation of critical metabolic and signaling pathways, e.g., PGC-1α expression and 
activation, mitochondrial biogenesis, enzymes involved in FAO, via phosphorylation of key downstream effectors 
and/or by regulation of gene expression41,42. In adipocytes, AMPK can be activated by cAMP32,43, perhaps via the 
increase in the AMP:ATP ratio due, at least in part, to activation of fatty acids released during lipolysis44,45. AMPK 
may be a critical mediator of many of the beneficial metabolic effects of the polyphenol resveratrol, which can 
act as a cAMP phosphodiesterase inhibitor46, and the antidiabetic drugs, metformin and TZDs47. Thus, AMPK is 
considered as a potential target to enhance exercise endurance48, and to treat obesity-related disorders49,50.
In this report, we show that targeted inactivation of the murine SvJ129 Pde3b gene was associated with acti-
vation of cAMP/PKA and AMPK signaling pathways, the integration of which resulted in “browning” of KO 
eWAT, with increased expression of genes and proteins related to mitochondrial biogenesis and function, ther-
mogenesis, and energy dissipation, including PRDM16, LRP130, PGC-1α , SIRT3, UCP1, ELOVL3, PPARα , and 
the enzymatic machinery for FAO. Results reported here suggest that PDE3B and/or its downstream signaling 
partners might be important regulators of energy metabolism and inflammation in adipose tissue, and potential 
therapeutic targets for treating obesity, diabetes and their associated metabolic disorders.
Results
Reduced weight gain by inhibiting PDE3B. PDE3B KO mice, which were generated as described in 
Methods, both male and female, gained less weight than wild type (WT) mice during high fat feeding from 40 to 
160 days after birth (Fig. 1A). KO eWAT fat pads were smaller than WT pads and “brownish” in color (Fig. 1B), 
and the percentage of eWAT weight relative to body weight was significantly reduced in KO mice, as compared 
to WT mice (Fig. 1C). Micro computed tomography (CT) scanning showed that the percentage of abdominal 
adipose tissue was significantly reduced in KO mice (WT, 8.5 ± 1.4%; KO, 5.7 ± 1.2%) (Fig. 1D). The percentage 
of gonadal fat weight relative to body weight was also reduced in both HE and KO male and female littermates 
compared to their WT littermates (Fig. S1). Similar to these results, we previously reported that eWAT mass 
and adipocyte size were decreased in age-matched male KO mice compared to WT, although body weight was 
increased in KO mice31. As seen in Fig. 1E, although immunoreactive cAMP response element-binding protein 
(CREB) was not increased in extracts from KO eWAT, phosphorylation of CREB as well as of other substrates of 
activated PKA, including perilipin and liver kinase B1 (LKB1), an upstream activating kinase of AMPK51, were 
increased. The reduction in immunoreactive exchange nucleotide protein activated by cAMP 1 (Epac1) and phos-
pho-calcium/calmodulin activated protein kinase (CAMK) in KO eWAT (Fig. 1F) suggests that Epac-induced 
activation of CAMK may not be important in activation of AMPK in KO eWAT52–54.
Development of the beige phenotype in PDE3B KO eWAT, with increased mitochondrial biogenesis 
and induction of its thermogenic program. Gene expression of the three critical coactivators of brown-
ing, PRDM1633, LRP13040,55 and PGC-1α 56 were increased more than 2-fold in KO eWAT (Fig. 2A), whereas 
expression of two suppressors, retinoblastoma protein 1 (Rb1) and p10757,58, were decreased (Fig. S2A). Western 
blots demonstrated that protein expression of Rb1 or p107 was decreased, and that inhibitory phosphorylation 
of Rb1 at Ser780 was increased (Fig. S2B). Gene expression of two other WAT corepressors, CtBP37 and nuclear 
receptor co-repressor (NCoR)59,60, were also significantly decreased (Fig. S2A). In KO eWAT, activated (deac-
ylated) PGC-1α protein and dramatically increased NAD+-dependent protein deacetylase 3 (SIRT3) protein 
were detected (Fig. 2B), PGC-1α being a key regulator in browning and in mitochondrial biogenesis25. PGC-1α 
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Figure 1. PDE3B KO mice are protected from obesity. (A) Weight gain in male and female PDE3B KO mice 
compared to WT under high-fat diets. Males (WT, n = 9; PDE3B KO, n = 9) and females (WT, n = 6; PDE3B 
KO, n = 9). (B) Smaller and brownish epididymal fat pads in PDE3B KO male mice. (C) Percent of eWAT weight 
to body weight (WT, n = 66; PDE3B KO, n = 46). (D) Abdominal fat mass of WT and PDE3B KO analyzed by 
Micro CT scanning; n = 4 mice per each group. (E) Immunoblots of PDE3B, CREB, and phosphorylated CREB 
levels (Upper); phosphorylated PKA substrate protein levels in whole lysates (Middle); and immunoprecipitates 
of perilipin in WT and PDE3B KO eWAT (Lower). (F) Immunoblots of EPAC, CAMKII and phosphorylated 
CAMKII levels in WT and PDE3B KO eWAT. Data are presented as mean ± SEM. ***p < 0.001, *p < 0.05 vs. WT.
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regulates transcription of the Sirt3 gene; SIRT3, in turn, regulates effects of cAMP (and PGC-1α ) on expression 
of BAT thermogenic genes, including UCP1, and thus may be important in development of the beige pheno-
type21,61. mRNA for nuclear receptor binding factor 1 (Nrbf1)15, a transcription factor regulating expression of 
mitochondrial respiratory proteins, was significantly increased (> 2 fold) in KO eWAT, as were mRNAs for β 1 
and β 3 adrenergic receptors (Adrb1 and Adrb3) (Fig. S2A) and ADRB3 protein (Fig. S2B), whose activation is 
important for function and recruitment of beige21 and BAT4,25,62. Expression of genes related to mitochondrial 
respiration (e.g. Cox4, cytochrome c oxidase subunit 4 isoform 1) (Fig. 2A) and immunoreactive mitochondrial 
COX1 (cytochrome c oxidase subunit 1) protein (Fig. S2B) were also increased in KO eWAT. Transient receptor 
potential vanilloid 4 (TRPV4) is a negative regulator of PGC-1α and UCP1 and a positive regulator of expression 
of proinflammatory genes63. Thus, the reduced protein expression of TRPV4 in KO eWAT may be important in 
recruitment/differentiation of beige adipocytes, i.e., increased expression of PGC-1α and induction of UCP164. 
The expression of several genes crucial to the beige fat thermogenic program was upregulated in KO eWAT. 
Elongase of very long chain fatty acid-like 3 (Elovl3), which is detected only in BAT and liver and is implicated 
in the thermogenic function of BAT65, was markedly increased in PDE3B KO eWAT (Fig. 2A). Ucp1, expressed 
almost exclusively in BAT mitochondria, was increased 31-fold (Fig. 2A). Cell death-inducing DNA fragmen-
tation factor, alpha subunit-like effector A (Cidea), encoding a mitochondrial protein important in regulation 
of energy balance and adiposity, in part by suppressing UCP1 activity66, was increased 11-fold (Fig. S2A), sug-
gesting coordinated control of energy metabolism in PDE3B KO eWAT. Type2 deiodinase (Dio2), induced by 
cAMP and essential for thyroid-sympathetic synergism in thermal homeostasis67,68, was also increased 3-fold 
(Fig. S2A). Western blot analysis demonstrated that KO eWAT expressed the BAT-specific marker proteins UCP1 
and CIDEA (Fig. 2B).
As seen in Fig. 2C, hematoxylin and eosin (H&E) staining of eWAT from WT and KO littermates and of WT 
interscapular BAT showed that cytoplasmic spaces in KO eWAT were thicker than WT eWAT, and more similar 
to that of BAT. Mitotracker staining indicated that mitochondrial density was increased in KO mice. Confocal 
microscopy image also showed that compared to WT eWAT, mitochondrial density was increased in KO eWAT 
Figure 2. PDE3B KO epididymal fat shows WAT-to-beige phenotypic conversion. (A) Quantitative 
PCR (qPCR) analysis of browning genes in eWAT of WT and PDE3B KO mice. (B) Immunoblot analysis of 
homogenates from WT and PDE3B KO eWAT and immuno-precipitates of PGC-1α . (C) Hematoxylin and 
Eosin (H&E) staining and MitoTracker staining from WT and PDE3B KO eWAT and WT interscapular BAT. 
Images are shown at 400x magnification. Scale bar, 50 μ m. (D) Mitochondrial-encoded DNA (mtDNA) and 
nuclear-encoded DNA (nDNA) content were presented as a ratio of mtDNA/nDNA with the WT ratio as 1. 
n = 7 mice per each group. (E) Mitochondrial fractions (upper and lower layers) were isolated from eWAT of 
WT and PDE3B KO mice and interscapular WT BAT via centrifugation in discontinuous sucrose gradients 
(25%, 35% and 45%). (F) Mitochondrial fractions were examined by electron microscopy. Scale bar, 1 micron. 
Data are presented as mean ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05 vs. WT.
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adipocytes, as were markers for vascular endothelium (CD31) and vascular smooth muscle actin (SMA) (Fig. S3). 
Mitochondrial staining and vascular markers in KO eWAT resembled interscapular BAT. Taken together, eWAT 
of KO mice acquired characteristics of BAT, including more blood vessels and mitochondria, which give it a 
“brownish” color4,25. Consistent with the observed increases in mitochondrial staining, KO eWAT mitochondrial 
DNA was increased (Fig. 2D). During purification of mitochondria via centrifugation in discontinuous sucrose 
gradients, WT interscapular BAT mitochondria sedimented as upper and lower bands, with the latter predomi-
nant. To a large extent, however, WT eWAT mitochondria sedimented as upper bands. KO eWAT mitochondria, 
on the other hand, sedimented in upper and lower bands”, similar to interscapular BAT mitochondria (Fig. 2E). 
As seen in electron micrographs of purified mitochondria (Fig. 2F), mitochondria from KO eWAT were larger 
than those from WT eWAT.
Increased energy dissipation by activation of AMPK signaling in PDE3B KO eWAT. As might 
be expected from the marked increase in UCP1 in PDE3B KO eWAT, mitochondrial respiration was uncoupled 
in KO mitochondria, compared to WT (Fig. 3A). FAO was significantly increased in isolated adipocytes from 
PDE3B KO mice compared to WT (Fig. 3B). Compared to WT, oxygen consumption was significantly increased 
in intact PDE3B KO mice following intraperitoneal (IP) injection of the β 3-specific adrenergic receptor ago-
nist, CL316243 (CL) (Fig. 3C), and in vitro in isolated eWAT (Fig. 3D) fragments from PDE3B KO mice. These 
results are consistent with PDE3B KO eWAT assuming phenotypic characteristics of beige adipose depots, i.e., an 
increase in mitochondrial biogenesis, with increased energy dissipation and FAO21,69.
As seen in Fig. 3E, to identify differences in WT and KO eWAT mitochondrial proteomes, WT and KO eWAT 
mitochondrial preparations analyzed by two-dimensional difference gel electrophoresis (DIGE) as described in 
SI Materials and Methods. After coomassie blue staining of DIGE gels (WT and KO mitochondria combined), 
a total of 145 protein spots of the eWAT mitochondrial proteome were identified by matrix-assisted laser des-
orption ionization (MALDI)-time-of-flight (TOF) MS/MS (Fig. S4). Based on image analysis of Cy3/Cy5 (KO/
WT) fluorescence of three independent DIGE gels using Progenesis Discovery software (NonLinear Dynamics, 
Durham, NC), relative differences in expression of MS/MS-identified proteins in WT and KO eWAT mitochon-
dria were calculated and represented as bar graphs (Fig. 3F and G) and listed in Table S2. As seen in Fig. 3F, 
DIGE results indicated that mitochondrial FAO-related proteins were significantly increased in KO eWAT mito-
chondria, including four isotypes of acyl-CoA dehydrogenase (ACAD), carnitine palmitoyltransferase 2 (CPT2), 
and α and β subunits of trifunctional protein (TP), all of which increased more than 1.5-fold. DIGE results also 
demonstrated that KO eWAT mitochondria were under less oxidative stress, in that expression of manganese 
superoxide dismutase (MnSOD), a mitochondrial antioxidant enzyme70, was lower in KO than WT (Fig. 3G). 
Higher expression of the Lon protease and its preferential substrate aconitase in mitochondria from KO eWAT 
indicated that they might be less damaged by oxidative stress, since oxidatively modified proteins are degradated 
by the Lon protease in the mitochondrial matrix71. The expression levels of mitochondria complexes I, II, III and 
IV were not significantly changed in KO mitochondria compared with WT (Table S2). To determine whether 
changes in mitochondria proteome were limited to adipose tissue, mitochondria isolated from WT and KO liver, 
spleen, heart and brain were analyzed. Although some spots demonstrated differential expression in each tissue, 
the overall differential changes in these tissues were fewer than those in eWAT mitochondrial proteomes from 
WT and PDE3B KO mice (Fig. S5).
In KO eWAT, LKB1 was activated, as evidenced by its auto-phosphorylation at Thr189 and phosphorylation 
at Ser431 (most likely via activated PKA) (Fig. 3H)72,73. Although immunoreactive AMPKα was not increased in 
KO eWAT, phosphorylation of AMPKα at Thr172, required for AMPK activation41, was significantly increased, 
as was AMPK enzymatic activity in PEG-precipitated fractions from KO eWAT (WT, 40.5 ± 8.7 unit/g/min; KO, 
87.0 ± 17.8 unit/g/min) (Fig. 3I). Protein expression of AMPK β 1 (a targeting subunit) was also increased in KO 
eWAT. Activation of AMPK was associated with decreased expression of acetyl-CoA carboxylase (ACC) protein 
and increased phosphorylation of ACC at Ser79 (Fig. 3H). Phosphorylation of ACC is thought to be critical in 
AMPK-induced reduction in malonyl CoA and activation of mitochondrial FAO74,75. Activation of FAO could 
be related to cAMP/PKA-induced phosphorylation/activation of SIRT1, leading to deacetylation/activation of 
PGC-1α and increased FAO, independent of changes in NAD+ 76. In addition, activation of AMPK in KO eWAT 
was associated with increased expression and phosphorylation/activation of endothelial nitric oxide synthase 
(eNOS) (Fig. S2C), an important regulator of mitochondrial biogenesis77. Expression of other proteins important 
in cAMP-signaling, i.e, PKA regulatory subunit II (PKA-RII) (Fig. S2C) and proteins involved in regulation of 
lipolysis, i.e., perilipin (Fig. 1E), adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL), were 
increased in KO eWAT, whereas another lipid droplet protein, lipid storage droplet protein-5 (LSDP5), was mark-
edly decreased (Fig. 3J). As seen in Fig. 3J, in KO eWAT, as compared to WT eWAT, HSL was relatively more 
heavily phosphorylated at Ser565, an AMPK-sensitive, inhibitory site78, than at Ser563, the PKA-sensitive activating 
site, consistent with previous findings in PDE3B KO mice, which indicated that, in the fed state, serum FFA were 
not elevated in KO mice31. On the other hand, AMPK has also been reported to phosphorylate/activate ATGL, 
which is critical in development of BAT and, perhaps, as a source of fatty acids for FAO79. Activation of AMPK 
and the subsequent phosphorylation (inactivation) of ACC (Fig. 3H) is important in regulation of FAO and 
of systemic insulin sensitivity41. As seen in Fig. S2A, expression of mRNAs for PPARα , a master nuclear tran-
scriptional regulator for FAO genes was increased more than 5-fold in PDE3B KO eWAT. PPARα protein, not 
detectable or barely detectable in WT eWAT25, was also increased in nuclear extracts from KO eWAT (Fig. 3K). 
Consistent with the result of DIGE, Western blotting of eWAT homogenates demonstrated that protein expres-
sion of two key enzymes important for fatty acids uptake into mitochondria, CPT1 and CPT2, was also increased 
in KO eWAT (Fig. S2D).
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Figure 3. Mice lacking PDE3B have increased metabolic rate due to an activation of AMPK signaling 
pathways. (A) GDP-sensitive proton leak (uncoupled respiration due to UCP1) in eWAT mitochondria from 
WT and PDE3B KO mice. n = 3 mice per each group. (B) Oxidation of [9,10(n)-3H]Palmitic acid (pmol 
oxidized/μ g DNA) in adipocytes from WT and PDE3B KO eWAT at indicated time points (0, 30, 60 and 
90 min). Values are presented as mean of three independent experiments. (C) Whole body O2 consumption in 
intact WT and PDE3B KO mice after intraperitoneal administration of indicated concentrations of CL316243 
(CL) (0, 4, 30, or 200 μ g/kg); n = 5 mice per each group. (D) In vitro O2 consumption in fragments of eWAT 
from WT and PDE3B KO mice; n = 7 mice per each group. (E) Two-dimentional difference gel electrophoresis 
(DIGE) of eWAT mitochondrial fractions from WT (n = 10) and PDE3B KO (n = 5) mice. The gel image is 
representative of three independent experiments. (F and G) Quantitative proteomics analysis of DIGE. Seven 
mitochondrial FAO-related enzymes (F) and three indicators of mitochondrial oxidative stress (G); n = 3 
DIGE gels. (H) Immunoblots showing LKB1, phosphorylated LKB1, AMPK, phosphorylated AMPK, ACC and 
phosphorylated ACC levels in WT and PDE3B KO eWAT. (I) AMPK activity in PEG-precipitated fractions of 
eWAT homogenates; n = 8 per each group. (J) Immunoblots showing HSL, phosphorylated HSL, ATGL and 
LSDP5 levels in WT and PDE3B KO eWAT. (K) An immunoblot showing PPARα levels in nuclear extracts from 
WT and PDE3B KO eWAT. (L) Model for Pde3b deletion-induced browning. In KO eWAT, cAMP-dependent 
PKA and AMPK pathway axis plays an important role in the regulation of the beige phenotype, energy homeostasis, 
FAO, and lipid metabolism.Data are presented as mean ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05 vs. WT.
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Role for PDE3B in cAMP/PKA- and AMPK-signaling in 3T3-L1 adipocytes. A regulatory role for 
PDE3B in induction of UCP1 in PDE3B KO eWAT was confirmed in 3T3-L1 adipocytes. In differentiated adipo-
cytes transfected with PDE3B siRNA, UCP1 mRNA was dramatically increased ~37 fold during incubation with 
CL compared to control oligonucleotide-transfected cells (Fig. 4A). Incubation of differentiated 3T3-L1 adipo-
cytes with cilostamide, a PDE3 inhibitor, also amplified the expression of UCP1 induced by CL and 8-CPT-cAMP, 
a cAMP analogue. Furthermore the induction of UCP1 by CL and 8-CPT-cAMP was inhibited by H89, a PKA 
inhibitor, suggesting a regulatory role for cAMP and PKA (Fig. 4B). As seen in Fig. 4C, inhibition of PDE3B with 
cilostamide increased phosphorylation of CREB at Ser133, AMPKα at Thr172, and ACC at Ser79, as well as of other 
unidentified PKA substrates. Rolipram, a PDE4 inhibitor, had a smaller effect on phosphorylation of AMPKα 
and ACC (Fig. 4C and D), suggesting PDE3B might regulate a distinct signaling pathway(s) that activates AMPK. 
The PKA inhibitor, Rp-8-Br-cAMPs, inhibited the effects of cilostamide and rolipram on phosphorylation of 
AMPK and ACC. Effects of cAMP on the activation status of PGC-1α were examined in differentiated 3T3-L1 
adipocytes, which were incubated with cilostamide or rolipram. Total solubilized protein (1 mg) from differen-
tiated 3T3-L1 adipocytes were immunoprecipitated with anti-PGC-1α antibody, and then immunoblotted with 
an anti-acetyl lysine antibody or the PGC-1α antibody, to determine both PGC-1α acetylation at lysine resi-
dues (Ac-Lys) and total PGC-1α protein. In contrast to PDE3B KO eWAT (Fig. 2B), expression of PGC-1α did 
Figure 4. Knockdown or chemical inhibition of PDE3B increases UCP1 expression by AMPK activation 
in 3T3-L1 adipocytes . (A) qPCR analysis of Pde3b and Ucp1 transcripts after PDE3B knockdown in 3T3-L1 
adipocytes; n = 3 experiments, duplicate assays. sc RNA, scrambled RNA; siPDE3B, PDE3B siRNA. (B) qPCR 
analysis of Ucp1 after PDE3 inhibition by cilostamide (10 μ M) or PKA inhibition by H89 (10 μ M) in 3T3-L1 
adipocytes. CL316243 (0.1 μ M) or 8-CPT-cAMP (100 μ M) were treated for 4 h. (C) Immunoblot analysis of 
3T3-L1 adipocytes after PDE3 inhibition by cilostamide (10 μ M) or rolipram (30 μ M). PKA-specific inhibitory 
cAMP analog (Rp-8-Br-cAMPs) were treated for 15 min. (D) Ratio of pACC/ACC (Upper) and pAMPK/
AMPK (Lower) are presented as bar graphs. (E) Immunoblot analysis of immunoprecipitates of PGC-1α from 
3T3-L1 adipocytes after PDE3 inhibition by cilostamide or rolipram. Blots represent one of three independent 
experiments. (F) Model for PDE3B inactivation-induced up-regulation of UCP1. Data are presented as 
mean ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05.
www.nature.com/scientificreports/
8Scientific RepoRts | 7:40445 | DOI: 10.1038/srep40445
not change in differentiated 3T3-L1 adipocytes treated with the PDE3 inhibitor cilostamide, but PGC-1α was 
deacetylated (activated) (Fig. 4E). Deacetylation of PGC-1α was also observed in the presence of rolipram.
Discussion
The phenotypic characteristics of PDE3B KO mice in SvJ129 background are complex, reflecting the role of 
PDE3B in tissues important for regulating energy homeostasis, i.e. adipose tissue, pancreas, and liver31. In KO 
mice, gonadal adipose tissue mass and eWAT adipocytes were smaller than their WT counterparts. Importantly, 
as demonstrated here, KO eWAT mice acquired characteristics of a beige phenotype, including changes in mor-
phology, increased expression of genes related to differentiation/recruitment of beige adipocytes, increased mito-
chondrial biogenesis, increased UCP1 (usually absent in WAT), increased FAO, and increased O2 consumption 
and energy dissipation21. Adiponectin, a circulating WAT-specific adipocytokine, may be responsible for some 
of these phenotypic changes. As reported earlier, serum adiponectin levels, which correlate inversely with per-
cent body fat, were significantly increased in KO mice31. Consistent with the phenotype of KO mice described 
herein, adiponectin has been reported to activate AMPK and FAO in liver and skeletal muscle, and also exert 
anti-inflammatory actions and cardioprotective effects80,81. These latter effects of adiponectin may also be related 
to activation of AMPK, which was reported to increase mitochondrial biogenesis and decrease reactive oxygen 
species (ROS) in human umbilical vein endothelial cells (HUVECs)82. Thus, PDE3B KO mice in SvJ129 back-
ground may provide a model for induction of beige adipocytes in WAT, recently postulated as a potential new 
strategy to combat diabetes and obesity-related diseases8,9,24,25.
cAMP is very important in the development of the beige phenotype and activation of its thermogenic pro-
gram21,22. As seen in Figs 1E and 3H, in KO eWAT, deletion of PDE3B increased cAMP/PKA signaling (phos-
phorylation of CREB and other PKA substrates including LKB1), as well as AMPK signaling, the integration of 
which resulted in upregulation of PGC-1α and PPARα , and induction of PRDM16 and LRP130 and suppression 
of Rb1, p107, CtBP and NCoR. As outlined in Fig. 3L and Fig. S8, in PDE3B KO eWAT, PRDM16, together with 
PGC-1α , PPARα , Nrbf-1 and other transcriptional regulators, i.e. CtBP, NCoR, LRP130, Rb1, and p107, initiated 
a coordinated metabolic program by upregulating PGC-1α , ELOVL3, CIDEA, and DIO2, and critical mitochon-
drial proteins, including UCP1, CPT2, CACT, ACAD, and phosphorylated ACC, which might be responsible for 
increased thermogenesis, energy dissipation, O2 consumption, and FAO in PDE3B KO eWAT. In 3T3-L1 adi-
pocytes, down-regulation of PDE3B, via pharmacologic inhibition with cilostamide or knockdown with siRNA 
PDE3B oligonucleotides, increased cAMP/PKA and AMPK signaling resulting in activation of PGC-1α and 
enhanced induction of UCP1 mRNA in response to CL or 8-CPT-cAMP (Fig. 4B). Thus, we suggest that, as sum-
marized in Figs 4F and S8, PDE3B may regulate a cAMP-sensitive molecular “switch” for “browning” of eWAT27. 
It is important to note that genetic background plays an important role in this PDE3B-regulated cAMP-sensitive 
WAT to beige phenotypic transition. In contrast to this current work with SvJ129 PDE3B KO mice, where dele-
tion of PDE3B alone was sufficient to induce the beige phenotype in KO eWAT, in C57BL/6 PDE3B KO mice, 
we reported that administration of the β 3 adrenoreceptor agonist, CL induced the beige transition83. Although 
several specific genes are considered as beige adipocyte markers, expression of these genes is quite variable in 
different types of adipocytes. As shown in Fig. S2E, solute carrier family 27 member 1 (Slc27a1, also known as 
Fatp1) was increased 2.7-fold and transmembrane 26 (Tmem26) and short stature homeobox-2 (Shox2) were 
significantly decreased in eWAT of PDE3B KO mice21,84–86.
Our data (Fig. 3L) support the idea that increased cAMP signaling in KO eWAT leads to activation of 
AMPK-signaling, perhaps via PKA-mediated phosphorylation/activation of LKB1. A complex between LKB1, 
mouse protein 25 (MO25), and STRAD (pseudokinase STE-related adaptor protein) has been identified as the 
major upstream kinase responsible for phosphorylation of AMPK on its activating loop at Thr172 87,88. ATGL, 
which apparently plays an important role in development of BAT and can be activated by AMPK79, is increased in 
KO eWAT and may generate fatty acids for FAO. AMP, generated during acylation of fatty acids released during 
lipolysis, binds to and activates phosphorylated AMPK (most likely phosphorylated by phosphorylated/activated 
LKB1)44. AMPK may also be phosphorylated/activated in KO eWAT a part of an autocrine response to increased 
serum adiponectin released from WAT in KO mice31,45,89. Activated AMPK can phosphorylate\inactivate ACC 
(Fig. 3H), leading to decreased production of malonyl CoA, which relieves inhibitory constraints on CPT1, a 
rate-limiting enzyme for activation of FAO (Fig. S2D)75. Analysis of isolated eWAT mitochondria by electron 
microscopic and proteomics techniques, and functional assays indicated that KO eWAT mitochondria were larger 
than WT and that the proteomic pattern in KO mitochondria was consistent with an increase in FAO-related 
proteins and decrease in the amount of oxidatively damaged proteins. Thus, as outlined in Fig. S8, not only were 
transcriptional regulators such as PGC-1α and PPARα and enzymatic machinery for FAO upregulated and neg-
ative regulators such as TRPV4 downregulated, but AMPK activity was increased, resulting in activation of FAO. 
Studies in 3T3-L1 adipocytes also indicated that cilostamide (PDE3 inhibitor) was more effective than rolipram 
(PDE4 inhibitor) in increasing phosphorylation of AMPK and ACC, suggesting that PDE3B regulated a cAMP 
“pool” important in regulation of AMPK and, perhaps, SIRT3 (Fig. 2B).
A recent report46 has suggested that many of the beneficial metabolic effects of the polyphenol resveratrol 
may be mediated by inhibition of cAMP PDEs, and, as shown in Table 1, the phenotypic changes in KO eWAT 
that result in activation of cAMP/PKA and AMPK signaling and increased mitochondrial biogenesis, FAO, and 
energy dissipation are quite similar to effects of administration of rosiglitazone to ob/ob mice90 or resveratrol to 
rodents46. This suggests that a switch to the beige phenotype and increased FAO in WAT may mediate some of the 
beneficial effects of insulin-sensitizing drugs such as rosiglitazone and resveratrol. The concept regarding salutary 
effects of acquisition of beige characteristics by WAT and enhanced energy dissipation is consistent with reports 
indicating that PGC-1α -responsive genes related to oxidative phosphorylation are coordinately down regulated 
in human diabetes14–16.
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PDE3B KO mice also exhibited signs of insulin resistance, with reduced glucose removal in response to 
insulin31. The liver is most likely the primary site, since insulin-induced suppression of glucose production, but 
not insulin-stimulated glucose uptake, was blocked in PDE3B KO mice31. Furthermore, in KO liver, cAMP was 
increased and, especially during a 6 h fast, PGC-1α expression was also increased as were key gluconeogenic 
enzymes, Trible-3, and inflammation/stress-related signaling molecules31. Thus, alterations in cAMP and PGC-1α 
may play critical roles in phenotypic characteristics of KO liver and eWAT. In adipose tissue, PGC-1α apparently 
regulates browning, adaptive thermogenesis, and mitochondrial function, biogenesis and respiration27. In liver, 
however, PGC-1α may also promote insulin resistance via co-activation of PPARα and induction of Trible-391. 
Although PDE3B KO mice show signs of insulin resistance31, they are lean and not diabetic, most likely due to 
development of the “fat-burning” beige phenotype and other characteristics of healthy KO eWAT discussed in 
this report, which compensate for the insulin resistance. In PDE3B KO mice, changes in adiponectin as well as 
the increase in insulin secretion in response to glucose, glucagon-like peptide1 and CL31, and the presence of 
smaller adipocytes and gonadal fat depots, as well as enhanced energy dissipation, might represent additional 
mechanisms that maintain or improve sensitivity to insulin, and/or prevent more marked insulin resistance and 
glucose intolerance. In this study we focused on eWAT since initially we noted pronounced changes in this depot. 
This was a little bit unexpected since most mouse work has focused on the subcutaneous inguinal white adipose 
tissue (iWAT), and its dynamics including feed/fasting, inflammation, and browning. Thus much of the systemic 
phenotype observed in PDE3B KO mice may still be due to changes in the iWAT depot.
In summary, PDE3B is an important regulator of lipid metabolism, adiposity, and energy status in adi-
pocytes (Fig. S8). PDE3B deficiency resulted in cAMP/PKA- and AMPK-induced increases in respiratory 
uncoupling and FAO, which could favorably impact energy homeostasis, circulating FFA, and insulin sensi-
tivity. Thus, adipocyte PDE3B, and/or cAMP pathways regulated by PDE3B, may provide new targets for the 
development of anti-obesity drugs designed to produce beneficial effects by inducing the beige phenotype 
in WAT.
Methods
PDE3B KO mice. PDE3B KO mice were progeny of 7–10 backcrosses of heterozygous (HE) F1 mice with 
JAX 129/SvJ (pTyrc-ch/pTyrc) substrain31. With primers from Pde3b exons 1/2 and 8/9, mRNA amplification in 
PDE3B KO eWAT was ~5% that of WT. With primers 3′ to exon 9, i.e. exons 9/10 and 15/16, mRNA amplifica-
tion was ~15% that of WT (Fig. S6A–C). PDE3 enzymatic activity was virtually absent in KO eWAT membrane 
fractions (Fig. S6E and F, Fig. S7A). There was very little PDE3 activity in WT or KO eWAT cytosol (Fig. S6E and 
F, Fig. S7F). As seen in Fig. S6, analysis of eWAT PDE3 activity and immunoreactivity after gel filtration chroma-
tography of solubilized membrane fractions and cytosolic fractions indicated that residual PDE3 activity in KO 
eWAT was related to the presence of PDE3A, not PDE3B, as previously suggested for residual PDE3 activity in 
PDE3B KO liver31. Mice were maintained, and studies performed, in accord with protocols (Protocol H-0024R4) 
Phenotypes and Markers PDE3B KO (eWAT) Rosiglitazone (ob/ob) Resveratrol
Epididymal Fat Pad
Fat Mass ↓ 31 ↓ 92
Adipocyte Size ↓ 31 ↓ ↓ 93
PKA/AMPK Signaling 
Pathways
Phosphorylated-PKA Substrates ↑ ↑ 94
Phosphorylated-CREB ↑ ↑ 95
Phosphorylated-Perilipin ↑ 
Phosphorylated AMPK ↑ ↑ 96 ↑ 46
Phosphorylated-ACC ↑ ↑ 96 ↑ 46
AMPK Activity ↑ ↑ 96 ↑ 46,97
Insulin Secretion ↑ 31 ↑ 98
Mitochondrial Biogenesis
Mitochondrial Mass ↑ ↑ ↑ 
Related Genes mRNA Protein mRNA Protein
UCP1 ↑ ↑ ↑ 90 ↑ 97
PGC-1α ↑ ↑ ↑ 90 ↑ 97
Acetylated-PGC-1α ↓ ↓ 
COX ↑ ↑ ↑ 90 ↑ 90 ↑ 99
CPT ↑ ↑ ↑ 90 ↑ 100
ACAD ↑ ↑ ↑ 90
Aconitase ↑ ↑ 90
FAO
PPARα ↑ ↑ 101 ↑ 102
Isolated Adipocytes ↑ ↑ ↑ 97
Oxygen Consumption
Isolated Adipose Tissue ↑ ↑ 
Intact Mice ↑ (+ β3 agonist)
C2C12 Myotubes ↑ 46
Table 1.  Comparison of effects of anti-diabetes drugs with eWAT phenotype in PDE3B KO mice.
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approved by the NHLBI Animal Care and Use Committee. Mice were fed high-fat-diet in the weight gain study, 
but all other experiments were done on chow diet.
Statistical Analysis. Data are expressed as mean ± SEM. Student’s t test was used for single variables, 
one-way ANOVA with Bonferroni post hoc correction was used for multiple comparisons and two-way ANOVA 
followed by Bonferroni posttests was used for multiple variables using GraphPad Prism 5 software. Values of 
p less than 0.05 were considered to be statistically significant and are presented as *(p < 0.05), **(p < 0.01), 
***(p < 0.001).
Further details are given in SI Materials and Methods.
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